早期检测急性冠状动脉综合征使用传统与新兴的生物化学标志物
Minakshi Kumari1, Saket Kumar2, Jhuma Das1
1Department of Biochemistry, Netaji Subhas Medical College and Hospital, Jamshedpur, Jharkhand, India.
Bioinformation
|July 10, 2025
概括
通过使用心型脂肪酸结合蛋白 (H-FABP) 和Troponin I生物标志物,可以改善急性冠状动脉综合征 (ACS) 的早期检测. 这些标记物为患者的ACS测试提供了卓越的诊断准确性.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
背景情况:
- 准确及时诊断急性冠状动脉综合征 (ACS) 对患者的治疗结果至关重要.
- 已知心脏生物标志物如Troponin I和CK-MB在早期检测方面存在局限性.
研究的目的:
- 评估新兴生物标志物 (H-FABP,Copeptin,IMA) 与急性冠状动脉综合征 (ACS) 的已知标志物 (Troponin I,CK-MB) 的诊断性能.
- 为了确定新型生物标志物是否可以提高早期ACS检测的灵敏度和准确性.
主要方法:
- 对150名患有暗示ACS的症状的患者进行前性分析.
- 对已知生物标志物 (Troponin I,CK-MB) 和新兴生物标志物 (H-FABP,Copeptin,IMA) 的检测.
- 生物标志物的敏感性,特异性和诊断准确性的统计比较.
主要成果:
- 心型脂肪酸结合蛋白 (H-FABP) 显示出最高的早期敏感性 (92%),表现优于Troponin I和CK-MB.
- 联合使用H-FABP和Troponin I显著改善了ACS检测 (p <0.05).
- 新兴生物标志物,特别是H-FABP,与单独使用标准标志物相比,显示出更高的诊断精度.
结论:
- H-FABP是用于早期ACS检测的高度敏感的生物标志物.
- 将H-FABP与Troponin I相结合,为ACS提供了卓越的诊断性能.
- 新兴的生物标志物对常规的ACS诊断协议来说是一个有价值的进步.
关键词:
急性冠状动脉综合征是什么科佩普丁 (copeptin) 是一种可以治疗的药物.肌酸激酶-MB (CK-MB) 的使用早期诊断 早期诊断 早期诊断心脏类型的脂肪酸结合蛋白 (H-FABP)缺血修饰的专辑蛋白.心肌损伤是指心肌损伤.热血素 I 热血素 I 在更多相关视频
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
16.8K
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
535
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
25
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
25
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
349
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
349
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
49
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
49
01:30Acute Coronary Syndrome I: Introduction
80
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
80
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
222
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
222
01:30Coronary Artery Disease I: Introduction
63
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
63